Chione Ltd's Form 4 filing
Acrivon Therapeutics, Inc. (ACRV) · filed Nov 21, 2022
- Accession no.
- 0001213900-22-074313
- Filed
- Nov 21, 2022, 6:26 PM ET
- Trade date
- Nov 17, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market purchases total $5.00M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chione LtdCIK 0001590232 | 10% Owner |
| Hadjimichael AndreasCIK 0001591256 | 10% Owner |
| Smolokowski WiaczeslawCIK 0001591274 | 10% Owner |
| Czernik MarcinCIK 0001591275 | 10% Owner |
| Nikolaou AnastasisCIK 0001954186 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 17, 2022 | Common Stock | PPurchaseAcquired | +400,000 | $12.50 | +$5,000,000 | 3,856,597 | Direct | |
| Nov 17, 2022 | Common Stock | CConversionAcquired | +3,445,940 | – | – | 3,856,597 | Direct | |
| Nov 17, 2022 | Common Stock | CConversionAcquired | +10,657 | – | – | 3,856,597 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 17, 2022 | Common Stock | CConversionDisposed | −3,445,940 | $0.00 | $0 | 0 | Direct | |
| Nov 17, 2022 | Common Stock | CConversionDisposed | −10,657 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.